about
Timely reperfusion for ST-segment elevation myocardial infarction: Effect of direct transfer to primary angioplasty on time delays and clinical outcomesEffect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIDouble Guide Catheter Technique for Sealing an Iatrogenic Coronary Perforation.Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.Safety and Efficacy of New Biodegradable Polymer-based Sirolimus-Eluting Stents in a Preclinical Model.Spain: coronary and structural heart interventions from 2010 to 2015.Primary Angioplasty in Patients Older Than 75 Years. Profile of Patients and Procedures, Outcomes, and Predictors of Prognosis in the ESTROFA IM+75 Registry.Spanish Cardiac Catheterization and Coronary Intervention Registry. 25th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2015).Transcatheter mitral valve interventions for mitral regurgitation, with special focus on MitraClip: The position of Spanish, Portuguese and Italian interventional societies.Safety and Efficacy of New Sirolimus-eluting Stent Models in a Preclinical Study.Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2.Emergency coronary stenting for acute occlusive dissection of the left main coronary artery.Platelet reactivity and stent thrombosis: still some issues to solve.Letter by Perez de Prado et al regarding article, "Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography".Closed-chest experimental porcine model of acute myocardial infarction-reperfusion.Endothelialization of nonapposed stent struts located over the origin of a side branch: results with different carbofilm-coated stents.Influence of platelet reactivity and response to clopidogrel on myocardial damage following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome.Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).Spanish Cardiac Catheterization and Coronary Intervention Registry. 26th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2016).Asymptomatic Intradialytic Supraventricular Arrhythmias and Adverse Outcomes in Patients on Hemodialysis.Combined Transcatheter Treatment of Ventricular Septal Rupture and Mitral Regurgitation After an Acute Myocardial Infarction.Comments on the 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-segment Elevation.Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.Selection of the Best of 2017 in Interventional Cardiology: Revolution in the Study of Coronary Physiology and New Parameters.Selection of the Best of 2017 in Left Atrial Appendage Occlusion: Filling the Gap in Knowledge.Selection of the Best of 2017 on Percutaneous Treatment of Chronic Occlusions.Transcatheter Tricuspid Repair With MitraClip in a Patient With a Failing De Vega Annuloplasty.Transbrachial intra-aortic balloon pump before urgent coronary artery bypass graft in a patient with severe peripheral atherosclerosis.Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.Late Left Coronary Artery Compromise After Corevalve Implantation: Insights From Instant Free Ratio Analysis.Clinical impact of intravascular ultrasound guidance in drug-eluting stent implantation for unprotected left main coronary disease: pooled analysis at the patient-level of 4 registries.Percutaneous mitral valve repair with MitraClip system in a patient with acute mitral regurgitation after myocardial infarction.Comparison of paclitaxel and everolimus-eluting stents in ST-segment elevation myocardial infarction and influence of thrombectomy on outcomes. ESTROFA-IM study.Safety and efficacy of different paclitaxel-eluting balloons in a porcine model.Spanish Cardiac Catheterization and Coronary Intervention Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Cardiac Catheterization and Interventional Cardiology (1990-2017)Baseline Risk Stratification of Patients Older Than 75 Years With Infarction and Cardiogenic Shock Undergoing Primary AngioplastyStudy design for the "effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion" (METOCARD-CNIC): a randomized, controlled parallel-group, observer-blinded clinical trial of early pre-reperfusion metoprolol administration in ST-sInvasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study DesignEndogenous Cardiac Stem Cell Activation by Insulin-Like Growth Factor-1/Hepatocyte Growth Factor Intracoronary Injection Fosters Survival and Regeneration of the Infarcted Pig Heart
P50
Q33812917-DA768260-16E0-41F8-AC95-0DFF05976DD1Q38445186-E966D14C-A8B3-45F7-A9BD-11EEDC229CE4Q38493281-648B4BBD-6A0E-4EE2-A293-0C317E251ECAQ38657816-FBF6BFF7-77AB-485F-8041-2ADB496854D6Q38710649-8E802F40-48C7-4F2E-A30C-BF3917C63253Q38786296-2F5596C8-DA75-40A9-8E81-CC653EABF5D5Q39191164-783442F5-22C2-46D1-B5E7-1A1AAFC1B998Q39211279-6C4DAC31-1C1A-44EA-9BC3-F3ED84B3D25AQ39307865-26B080D0-BB1B-4BBA-A421-32FFF45AD8CAQ40701839-68B19329-4B28-422D-B65B-FEEB19D3C24BQ41671886-BFAB67EC-CDFD-44D3-BCC5-5AF8F88CA88AQ42065901-B6BA6C8A-AE27-4934-B0D3-F2F6B43A48B5Q43297420-C499D534-5CF0-4CE4-A100-B4BBA9C54DDDQ45894956-3414BC8C-544D-4E71-954F-14999D84E707Q45985545-6B9DCAE5-437D-4EC5-9B0B-E5FF6668B1EFQ45985864-47157816-441B-4343-9A30-FDF7B057539FQ46027669-F4778C9A-8B95-4D1A-B2F0-1A884CF9DDA7Q46679962-AB869A41-7EE0-4B5E-A7A3-1DF85B934D2AQ46714815-541BB75C-8C1B-47AB-916F-3D7753299CD4Q47371760-697555C7-811F-462A-9A89-261CF8DE6A49Q47989402-D8B20C40-7AAF-4C11-B464-CD4DF0B5667FQ49340353-09B954EF-F9C2-4E29-B935-4911D6C9D49EQ49340597-BFAF2460-AF4B-489A-813A-834AC6E4D170Q49581357-AB3BA1C2-6F58-409A-BAFF-884FD2BD42E6Q49794881-4FB5A6BA-E0BC-42DD-9823-D93456E7CA90Q49904922-E5D46D49-321A-4E5F-8399-F6139F332D9DQ50056644-E7093A14-EE19-4DAF-A30D-AAE15DF511B7Q50063872-8F3E9D08-58B4-428F-8343-E95191FEE635Q50134702-9882A98C-4F20-4938-A5AF-816BCF7A3A02Q50147849-E38E7A48-1D06-4839-8C09-AC0A7638AC26Q50939351-26B77AF2-D502-4D6E-B9EA-6230A146DBB6Q51747144-057F553C-38BC-4DC8-8EB1-BA3A98EDD976Q53332196-7626FCC8-BED4-483C-879B-831598EA7EACQ53383301-328C9A2A-623A-4282-BBA2-24E25232B0A4Q53541062-A95C13C6-6A94-4CA5-91ED-1182B5CEE6C6Q57297728-F61420D6-49D9-4EC7-B0B3-2C02AAFFFFE5Q57297729-66F9ED05-DE56-47F6-898C-95A659BD1DC0Q57761299-635F7458-6F1A-4C72-959D-71175DA528B1Q61670791-FC7A75EF-2D28-442B-B59F-BE04BA0F28E9Q61865092-73441529-5C72-452A-82EC-16C745A4A827
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Armando Pérez de Prado
@ast
Armando Pérez de Prado
@en
Armando Pérez de Prado
@es
type
label
Armando Pérez de Prado
@ast
Armando Pérez de Prado
@en
Armando Pérez de Prado
@es
altLabel
A.P. de Prado
@en
prefLabel
Armando Pérez de Prado
@ast
Armando Pérez de Prado
@en
Armando Pérez de Prado
@es
P1053
D-2922-2009
P106
P1153
6602985842
P21
P31
P3829
P496
0000-0003-3283-0597